Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed: 18,156
Companies: 1,062
Drugs tracked: 3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources

Quick answer

recombinant interferon alfa

selenase (selenium)

trastuzumab

treprostinil sodium

vitamin A supplementation (15,000 ug retinol equivalents or 50,000 IU)

zinc sulphate dietary supplement

0.5% Ivermectin lotion

1. Intranasal oxytocin spray

10 GE Xenokidney

177Lu-J591

177Lu-PSMA-617

2-deoxyglucose

225Ac-J591

2mg Buprenex and 380mg Vivitrol

3,4-Methylenedioxymethamphetamine (MDMA)

60 mg Prednisone

70 mL red beetroot juice

ADENOVIRUS/PSA VACCINE

APD811

AZD2014

AZD5069

AZD5363

AZD6738

AZD8931

Frequently asked questions